Skip to Content

WPI 2287 (Propafenone hydrochloride extended-release 425 mg)

This pill with imprint "WPI 2287" is White, Capsule-shape and has been identified as Propafenone hydrochloride extended-release 425 mg. It is supplied by Actavis Pharma, Inc..

Propafenone is used in the treatment of atrial fibrillation; atrial flutter; wolff-parkinson-white syndrome; ventricular tachycardia and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Propafenone 425 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for WPI 2287

Propafenone hydrochloride extended-release

Imprint:
WPI 2287
Strength:
425 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Group I antiarrhythmics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Actavis Pharma, Inc.
National Drug Code (NDC):
00591-2287

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide